Green Tea Extract in Treating Patients With Nonmetastatic Bladder Cancer
Completed · Phase 2 · Has a placebo group
Conditions studied: Stage I Bladder Cancer, Stage II Bladder Cancer, Stage III Bladder Cancer
In brief
Green tea extract contains ingredients that may slow the growth of certain cancers. It is not yet known whether green tea extract is more effective than a placebo when given before surgery in treating patients with bladder. This randomized phase II trial is studying green tea extract to see how well it works compared to a placebo when given before surgery in treating patients with nonmetastatic bladder cancer.
Key facts
- Study ID
- NCT00666562
- Run by
- National Cancer Institute (NCI)
- People needed
- 31
- Starts
- 2008-07-02
- Expected to finish
- 2017-06-09
- Last updated by the study team
- 2017-11-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- University of Alabama at Birmingham Cancer Center — Birmingham, Alabama, United States
- Lahey Hospital and Medical Center — Burlington, Massachusetts, United States
- Minneapolis Veterans Medical Center — Minneapolis, Minnesota, United States
- University of Rochester — Rochester, New York, United States
- Urology San Antonio Research PA — San Antonio, Texas, United States
- University of Wisconsin Hospital and Clinics — Madison, Wisconsin, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.